Skip to main content
Clinical Trials/KCT0004179
KCT0004179
Not Yet Recruiting
N/A

The Comparative study of Voice quality improvement according to Ilaprazole administration on Laryngopharyngeal reflux disease patients with Voice change

Koera University Guro Hospital0 sites140 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Diseases of th respiratory system
Sponsor
Koera University Guro Hospital
Enrollment
140
Status
Not Yet Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Koera University Guro Hospital

Eligibility Criteria

Inclusion Criteria

  • (1\) Those who don't lack decision\-making capacity, with the age of between 19 and 75
  • (2\) Those suffering from voice disorder with the score of Reflux Symptom index (RSI) and Reflux Finding score (RFS) higher than 13 and 7 point.
  • (3\) Those who agree to participate in this clinical trial voluntarily.

Exclusion Criteria

  • (1\) Those sensitive to class of Ilaprazole (Proton pump inhibitor)
  • (2\) Those with history of malignant tumor
  • (3\) Those with need to take Warfarin, Coumarin, Aspirin(higher then 325mg/d) or steroid consistently.
  • (4\) Those with history of surgery or treatment due to Gastroesophageal reflux disease (GERD)
  • (5\) Those with history of Gastric acid suppression
  • (6\) Those with history of significant surgery which has impact on Gastric acid secretion
  • (7\) Those taking Gastric acid suppression medicine
  • (8\) Mental illiness patient, alcohol addictor or those with history of drug abuse
  • (9\) Pregnant and lactating women
  • (10\) Childbearing women (Menopausal women who are amenorrheic for at least 12 months are considered to be non\-childbearing women.)

Outcomes

Primary Outcomes

Not specified

Similar Trials